Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Diana Dawson
Regulatory Coordinator II
Cancer Center Division
Overview
Research
More
Collaboration
(15)
Brianna Denton
Mutual work: 5 Grants﹒7 Proposals﹒1 Supervisor
Collaboration Details
Bryan Clines
Mutual work: 3 Grants﹒4 Proposals
Collaboration Details
Hina Arif Tiwari
Mutual work: 5 Grants﹒6 Proposals
Collaboration Details
Rachna Shroff
Mutual work: 12 Proposals﹒9 Grants
Collaboration Details
Michele Chu-Pilli
Mutual work: 1 Grant
Collaboration Details
Page 1 of 3
Previous page
Next page
Grants
(11)
A Phase 1b Study of the OxPhos Inhibitor ME-344 Combined With Bevacizumab in Previously Treated Metastatic Colorectal Cancer
Active
·
2024
·
$0 / $502.8K
·
External
undefined (CD)
cancer,
metastasis,
drug combination,
treatment,
clinical trial
A Phase 2a, Double-Blind, Placebo-Controlled, Multi-Center, Randomized Study Evaluating LSTA1 when Added to Standard of Care (SOC) Versus Standard of Care Alone in Subjects with Advanced Solid Tumors
Active
·
2023
·
$0 / $825.5K
·
External
undefined (CD)
oncology,
clinical trials,
immunotherapy,
cancer treatment,
drug efficacy
A Phase 1 Dose-Escalation Study of FF-10832 for the Treatment of Advanced Solid Tumors and Lymphomas
Active
·
2023
·
$0 / $684.8K
·
External
undefined (CD)
cancer treatment,
drug trial,
dose escalation,
solid tumors,
lymphomas
Randomized Phase 2 Study of DKN-01 Plus FOLFIRI/FOLFOX and Bevacizumab Versus FOLFIRI/FOLFOX and Bevacizumab as Second-line Treatment of Advanced Colorectal Cancer (DeFianCe)
Active
·
2023
·
$0 / $568.2K
·
External
undefined (CD)
colorectal cancer,
treatment,
clinical trial,
dkn-01,
chemotherapy
A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers
Active
·
2023
·
$0 / $509.8K
·
External
undefined (CD)
cancer,
chemotherapy,
clinical trial,
treatment,
combination therapy
Page 1 of 3
Previous page
Next page